Advanced search
Publication Cover
Bioanalysis Volume 12, 2020 - Issue 22
Submit an article Journal homepage
2,618
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LC–MS/MS Assays to Quantify Sulfatides and Lysosulfatide in Cerebrospinal Fluid of Metachromatic Leukodystrophy Patients

Karen (Hongmei) Cao1 Shire, a member of The Takeda Group of Companies, 125 Binney Street, Cambridge, MA02142, USA;3 Present address: Alnylam Pharmaceuticals, 300 Third Street, Cambridge, MA02142, USACorrespondence[email protected]
View further author information
,
Guodong Zhang1 Shire, a member of The Takeda Group of Companies, 125 Binney Street, Cambridge, MA02142, USA;3 Present address: Alnylam Pharmaceuticals, 300 Third Street, Cambridge, MA02142, USAView further author information
,
Leslie Jacobsen2 Shire, a member of The Takeda Group of Companies, 300 Shire Way, Lexington, MA02421, USA;4 Present address: AVROBIO, One Kendall Square, Building 300, Suite 201, Cambridge, MA02139, USAView further author information
&
Jiang Wu1 Shire, a member of The Takeda Group of Companies, 125 Binney Street, Cambridge, MA02142, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6445-8788View further author information
ORCID Icon
Pages 1621-1633 | Received 17 Jul 2020, Accepted 24 Sep 2020, Published online: 05 Nov 2020

References

  • Gieselmann V , Krägeloh-MannI. Metachromatic leukodystrophy. In: Scriver’s Online Metabolic and Molecular Bases of Inherited Disease.ValleD, BeaudetAL, VogelsteinB ( Eds). McGraw-Hill, NY, USA (2018).
  • Gomez-Ospina N . Arylsulfatase A deficiency. In: GeneReviews®. AdamMP (Ed.). WA, USA (2017).
  • Gieselmann V . Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. Acta Paediatr.97(457), 15–21 (2008).
  • Gieselmann V , Krageloh-MannI. Metachromatic leukodystrophy: an update. Neuropediatrics41(1), 1–6 (2010).
  • Kehrer C , BlumenstockG, GieselmannV, Krageloh-MannI, GermanL. The natural course of gross motor deterioration in metachromatic leukodystrophy. Dev. Med. Child Neurol.53(9), 850–855 (2011).
  • Van Rappard DF , BoelensJJ, WolfNI. Metachromatic leukodystrophy: disease spectrum and approaches for treatment. Best Pract. Res. Clin. Endocrinol. Metab.29(2), 261–273 (2015).
  • Groeschel S , KuhlJS, BleyAEet al. Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients. JAMA Neurol.73(9), 1133–1140 (2016).
  • Baldo BA . Enzymes approved for human therapy: indications, mechanisms and adverse effects. BioDrugs29(1), 31–55 (2015).
  • Whiteman DA , KimuraA. Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future. Drug Des. Devel. Ther.11, 2467–2480 (2017).
  • Shire . Long-term metazym treatment of patients with late infantile metachromatic leukodystrophy (MLD) (2020). https://clinicaltrials.gov/ct2/show/results/NCT00633139?view=results
  • Í Dali C , SevinC, Krageloh-MannIet al. Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a Phase I/II clinical trial. Mol. Genet. Metab. doi:10.1016/j.ymgme.2020.07.002 (2020) ( Epub ahead of print).
  • Troy S , WasilewskiM, BeusmansJ, GodfreyCJ. Pharmacokinetic modeling of intrathecally administered recombinant human arylsulfatase A (TAK-611) in children with metachromatic leukodystrophy. Clin. Pharmacol. Ther.107(6), 1394–1404 (2020).
  • Kuchar L , AsfawB, PoupetovaH, HonzikovaJ, TurecekF, LedvinovaJ. Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy. Clin. Chim. Acta425, 153–159 (2013).
  • Mirzaian M , KramerG, PoorthuisBJ. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry. J. Lipid Res.56(4), 936–943 (2015).
  • Spacil Z , BabuKumar A, LiaoHCet al. Sulfatide analysis by mass spectrometry for screening of metachromatic leukodystrophy in dried blood and urine samples. Clin. Chem.62(1), 279–286 (2016).
  • Blomqvist M , BorenJ, ZetterbergH, BlennowK, ManssonJE, StahlmanM. High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS. J. Lipid Res.58(7), 1482–1489 (2017).
  • US FDA . Bioanalytical Method Validation Guidance for Industry (2020). http://academy.gmp-compliance.org/guidemgr/files/UCM368107.PDF
  • Harvey AR . The Gross Motor Function Measure (GMFM). J. Physiother.63(3), 187 (2017).
  • Dali CI , BartonNW, FarahMHet al. Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy. Ann. Clin. Transl. Neurol.2(5), 518–533 (2015).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.